Translation of reporter mRNAs is repressed by endogenous let-7a in HeLa cells. (A) The sequence of the C. elegans lin-41 3′ UTR is shown with the two experimentally confirmed (33) LCSs in boxes. The 85-bp sequence containing two LCSs and a spacer region that was inserted into reporter constructs is shown in bold. (B) The plasmid constructs used in C–F. FF4LCS contains the FF luciferase ORF with two of the boldfaced regions in A, containing four boxed LCSs, inserted into the 3′ UTR. FFr4mLCS contains the FF luciferase reporter with the bolded region in reverse orientation and the four LCSs mutated. Each LCS is shown as a white box, and mutated LCSs are gray boxes, with arrows denoting forward or reverse orientation. The FF reporters were transcribed from the CMV or the HSV-TK promoter. Also shown are the cotransfected R luciferase reporter under the control of the alternate promoter and the equation used to calculate the translation efficiency. (C) HeLa cells were transfected with plasmids depicted in B using the cationic lipid formulation TransIT-HeLaMONSTER (Mirus). FF luciferase activity was measured and normalized to R luciferase activity, and then the forward LCS-containing constructs were normalized to the reversed, mutated control (FF4LCS/FFr4mLCS; FFr4mLCS value set to 1). The first lane represents the untransfected control, which had no activity above background. (D) Denaturing, polyacrylamide gel analysis of RNA harvested from transfected cells and subjected to RNase protection analysis. (E) The gel of the RNase protection analysis in D was quantified, and the FF mRNA value was normalized to R mRNA, which was then normalized to the reversed, mutated control (value set to 1). (F) The luciferase activity in C was normalized to the mRNA levels determined in E and then normalized again to their reversed, mutated controls to obtain the translation efficiency. Error bars represent standard deviations from three experiments.